Literature DB >> 17367885

PICK1 is not a susceptibility gene for schizophrenia in a Japanese population: association study in a large case-control population.

H Ishiguro1, M Koga, Y Horiuchi, T Inada, N Iwata, N Ozaki, H Ujike, T Muratake, T Someya, T Arinami.   

Abstract

The protein interacting with C-kinase 1 (PICK1) has been implicated in the susceptibility to schizophrenia. PICK1 interacts with enzymes and receptors that play roles in the pathogenesis of schizophrenia via glutamatergic dysfunction. Recently, two studies reported associations between schizophrenia and two PICK1 gene polymorphisms, rs3952 in Chinese and Japanese populations and rs2076369 in a Japanese population. We attempted to confirm these associations in a case-control study of 1765 Japanese patients with schizophrenia and 1851 Japanese control subjects. Neither polymorphism was associated with schizophrenia (rs3952, p=0.755; rs2076369, p=0.997). A haplotype block with these polymorphisms spanning the 5' region of the PICK1 gene showed high linkage disequilibrium in the Japanese population (D'=0.98, r(2)=0.34); however, neither haplotype was significantly associated with schizophrenia. We conclude that the common haplotypes and polymorphisms of the PICK1 gene identified thus far are unlikely to contribute to genetic susceptibility to schizophrenia in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17367885     DOI: 10.1016/j.neures.2007.02.008

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  7 in total

1.  Alu-mediated deletion of SOX10 regulatory elements in Waardenburg syndrome type 4.

Authors:  Nadége Bondurand; Virginie Fouquet; Viviane Baral; Laure Lecerf; Natalie Loundon; Michel Goossens; Benedicte Duriez; Philippe Labrune; Veronique Pingault
Journal:  Eur J Hum Genet       Date:  2012-02-29       Impact factor: 4.246

Review 2.  Cellular and pathophysiological consequences of Arp2/3 complex inhibition: role of inhibitory proteins and pharmacological compounds.

Authors:  Sandra Chánez-Paredes; Armando Montoya-García; Michael Schnoor
Journal:  Cell Mol Life Sci       Date:  2019-05-09       Impact factor: 9.261

Review 3.  Dopamine genes and schizophrenia: case closed or evidence pending?

Authors:  Michael E Talkowski; Mikhil Bamne; Hader Mansour; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-07-14       Impact factor: 9.306

4.  The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment.

Authors:  Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro; Andrea de Bartolomeis
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

5.  PICK1 Genetic Variation and Cognitive Function in Patients with Schizophrenia.

Authors:  Yi-Ting Chen; Chieh-Hsin Lin; Chiung-Hsien Huang; Wen-Miin Liang; Hsien-Yuan Lane
Journal:  Sci Rep       Date:  2017-05-15       Impact factor: 4.379

Review 6.  The Scaffold Protein PICK1 as a Target in Chronic Pain.

Authors:  Andreas Toft Sørensen; Joscha Rombach; Ulrik Gether; Kenneth Lindegaard Madsen
Journal:  Cells       Date:  2022-04-07       Impact factor: 7.666

7.  Population-specific haplotype association of the postsynaptic density gene DLG4 with schizophrenia, in family-based association studies.

Authors:  Shabeesh Balan; Kazuo Yamada; Eiji Hattori; Yoshimi Iwayama; Tomoko Toyota; Tetsuo Ohnishi; Motoko Maekawa; Manabu Toyoshima; Yasuhide Iwata; Katsuaki Suzuki; Mitsuru Kikuchi; Takeo Yoshikawa
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.